Table of Contents Author Guidelines Submit a Manuscript
Disease Markers
Volume 2015 (2015), Article ID 879254, 8 pages
http://dx.doi.org/10.1155/2015/879254
Research Article

miR-34a Inhibits Proliferation and Invasion of Bladder Cancer Cells by Targeting Orphan Nuclear Receptor HNF4G

1Department of Hemodialysis, Qilu Hospital, Shandong University, Jinan 250012, China
2Department of Nephrology, Qilu Hospital, Shandong University, Jinan 250012, China

Received 8 December 2014; Accepted 2 March 2015

Academic Editor: Silvia Persichilli

Copyright © 2015 Huaibin Sun et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. W. G. van Rhijn, M. Burger, Y. Lotan et al., “Recurrence and progression of disease in non-muscle-invasive bladder cancer: from epidemiology to treatment strategy,” European Urology, vol. 56, no. 3, pp. 430–442, 2009. View at Publisher · View at Google Scholar · View at Scopus
  2. C. Murta-Nascimento, B. J. Schmitz-Dräger, M. P. Zeegers et al., “Epidemiology of urinary bladder cancer: from tumor development to patient's death,” World Journal of Urology, vol. 25, no. 3, pp. 285–295, 2007. View at Publisher · View at Google Scholar · View at Scopus
  3. P. J. Goebell and M. A. Knowles, “Bladder cancer or bladder cancers? Genetically distinct malignant conditions of the urothelium,” Urologic Oncology: Seminars and Original Investigations, vol. 28, no. 4, pp. 409–428, 2010. View at Publisher · View at Google Scholar · View at Scopus
  4. D. P. Bartel, “MicroRNAs: genomics, biogenesis, mechanism, and function,” Cell, vol. 116, no. 2, pp. 281–297, 2004. View at Publisher · View at Google Scholar · View at Scopus
  5. G. A. Calin and C. M. Croce, “MicroRNA signatures in human cancers,” Nature Reviews Cancer, vol. 6, no. 11, pp. 857–866, 2006. View at Publisher · View at Google Scholar · View at Scopus
  6. P. E. Blower, J.-H. Chung, J. S. Verducci et al., “MicroRNAs modulate the chemosensitivity of tumor cells,” Molecular Cancer Therapeutics, vol. 7, no. 1, pp. 1–9, 2008. View at Publisher · View at Google Scholar · View at Scopus
  7. D. Lodygin, V. Tarasov, A. Epanchintsev et al., “Inactivation of miR-34a by aberrant CpG methylation in multiple types of cancer,” Cell Cycle, vol. 7, no. 16, pp. 2591–2600, 2008. View at Publisher · View at Google Scholar · View at Scopus
  8. C. Zhang, Z. Yao, M. Zhu et al., “Inhibitory effects of MicroRNA-34a on cell migration and invasion of invasive urothelial bladder carcinoma by targeting Notch1,” Journal of Huazhong University of Science and Technology (Medical Science), vol. 32, no. 3, pp. 375–382, 2012. View at Publisher · View at Google Scholar · View at Scopus
  9. W. Wang, T. Li, G. Han, Y. Li, L.-H. Shi, and H. Li, “Expression and role of miR-34a in bladder cancer,” Indian Journal of Biochemistry & Biophysics, vol. 50, no. 2, pp. 87–92, 2013. View at Google Scholar · View at Scopus
  10. L. He, X. He, L. P. Lim et al., “A microRNA component of the p53 tumour suppressor network,” Nature, vol. 447, no. 7148, pp. 1130–1134, 2007. View at Publisher · View at Google Scholar · View at Scopus
  11. T.-C. Chang, E. A. Wentzel, O. A. Kent et al., “Transactivation of mir-34a by p53 broadly influences gene expression and promotes apoptosis,” Molecular Cell, vol. 26, no. 5, pp. 745–752, 2007. View at Publisher · View at Google Scholar · View at Scopus
  12. R. L. Vinall, A. Z. Ripoll, S. Wang, C.-X. Pan, and R. W. D. White, “MiR-34a chemosensitizes bladder cancer cells to cisplatin treatment regardless of p53-Rb pathway status,” International Journal of Cancer, vol. 130, no. 11, pp. 2526–2538, 2012. View at Publisher · View at Google Scholar · View at Scopus
  13. H. Li, G. Yu, R. Shi et al., “Cisplatin-induced epigenetic activation of miR-34a sensitizes bladder cancer cells to chemotherapy,” Molecular Cancer, vol. 13, no. 1, article 8, 2014. View at Publisher · View at Google Scholar · View at Scopus
  14. S. D. Cho, S.-O. Lee, S. Chintharlapalli et al., “Activation of nerve growth factor-induced Bα by methylene-substituted diindolylmethanes in bladder cancer cells induces apoptosis and inhibits tumor growth,” Molecular Pharmacology, vol. 77, no. 3, pp. 396–404, 2010. View at Publisher · View at Google Scholar · View at Scopus
  15. T. Inamoto, B. A. Czerniak, C. P. Dinney, and A. M. Kamat, “Cytoplasmic mislocalization of the orphan nuclear receptor Nurr1 is a prognostic factor in bladder cancer,” Cancer, vol. 116, no. 2, pp. 340–346, 2010. View at Publisher · View at Google Scholar · View at Scopus
  16. T. Okegawa, K. Ushio, M. Imai, M. Morimoto, and T. Hara, “Orphan nuclear receptor HNF4G promotes bladder cancer growth and invasion through the regulation of the hyaluronan synthase 2 gene,” Oncogenesis, vol. 2, article e58, 2013. View at Publisher · View at Google Scholar · View at Scopus
  17. H. Tazawa, N. Tsuchiya, M. Izumiya, and H. Nakagama, “Tumor-suppressive miR-34a induces senescence-like growth arrest through modulation of the E2F pathway in human colon cancer cells,” Proceedings of the National Academy of Sciences of the United States of America, vol. 104, no. 39, pp. 15472–15477, 2007. View at Publisher · View at Google Scholar · View at Scopus
  18. D. C. Corney, C.-I. Hwang, A. Matoso et al., “Frequent downregulation of miR-34 family in human ovarian cancers,” Clinical Cancer Research, vol. 16, no. 4, pp. 1119–1128, 2010. View at Publisher · View at Google Scholar · View at Scopus
  19. C. Liu, K. Kelnar, B. Liu et al., “The microRNA miR-34a inhibits prostate cancer stem cells and metastasis by directly repressing CD44,” Nature Medicine, vol. 17, no. 2, pp. 211–216, 2011. View at Publisher · View at Google Scholar · View at Scopus
  20. V. Tarasov, P. Jung, B. Verdoodt et al., “Differential regulation of microRNAs by p53 revealed by massively parallel sequencing: miR-34a is a p53 target that induces apoptosis and G1-arrest,” Cell Cycle, vol. 6, no. 13, pp. 1586–1593, 2007. View at Publisher · View at Google Scholar · View at Scopus
  21. B. Zhou, H. Yi, J. Tan, Y. Wu, G. Liu, and Z. Qiu, “Anti-proliferative effects of polyphenols from pomegranate rind (Punica granatum L.) on EJ bladder cancer cells via regulation of p53/mir-34a axis,” Phytotherapy Research, vol. 29, no. 3, pp. 415–422, 2015. View at Publisher · View at Google Scholar
  22. P. Germain, B. Staels, C. Dacquet, M. Spedding, and V. Laudet, “Overview of nomenclature of nuclear receptors,” Pharmacological Reviews, vol. 58, no. 4, pp. 685–704, 2006. View at Publisher · View at Google Scholar · View at Scopus
  23. G. Benoit, A. Cooney, V. Giguere et al., “International union of pharmacology. LXVI. Orphan nuclear receptors,” Pharmacological Reviews, vol. 58, no. 4, pp. 798–836, 2006. View at Publisher · View at Google Scholar · View at Scopus
  24. X. Wang, M. Li, Z. Wang et al., “Silencing of long noncoding rna malat1 by mir-101 and mir-217 inhibits proliferation, migration, and invasion of esophageal squamous cell carcinoma cells,” The Journal of Biological Chemistry, vol. 290, no. 7, pp. 3925–3935, 2015. View at Publisher · View at Google Scholar